[{"Assets_0_FY_USD":11734500000.0,"NetCashProvidedByUsedInOperatingActivitiesConverted_4_FY_USD":2195100000.0,"NetIncomeLossConverted_1_FY_USD":820400000.0,"NetIncomeLossConverted_4_FY_USD":2444400000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_4_FY_shares":114800000.0,"WeightedAverageNumberOfSharesOutstandingBasic_4_FY_shares":107900000.0,"StockholdersEquity_0_FY_USD":8757300000.0,"EarningsPerShareBasic_1_FY_USD":7.58,"EarningsPerShareBasic_4_FY_USD":22.65,"EarningsPerShareDiluted_1_FY_USD":7.15,"EarningsPerShareDiluted_4_FY_USD":21.29,"RevenuesConverted_1_FY_USD":1927800000.0,"RevenuesConverted_4_FY_USD":6710800000.0,"Ticker":"REGN","CIK":"872589","name":"REGENERON PHARMACEUTICALS INC","OfficialName":"Regeneron Pharmaceuticals Inc. Common Stock","form":"10-K","period":"20181231","fy":"2018.0","fp":"FY","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"77738004554.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"SP500","filed":"20190207"}]